Skoči na glavni sadržaj

Ostalo

https://doi.org/10.20471/may.2020.57.01.09

Ansofaxine Hydrochloride

Vjekoslav Peitl orcid id orcid.org/0000-0003-4163-6411 ; Klinika za psihiijatriju KBC Sestre milosrdnice
Darko Vlahović orcid id orcid.org/0000-0002-4693-3450 ; Klinika za psihijatriju KBC Sestre milosrdnice, Zagreb, Hrvatska


Puni tekst: engleski pdf 271 Kb

str. 99-102

preuzimanja: 857

citiraj


Sažetak

Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor that inhibits serotonin, dopamine and norepinephrine reuptake. This novel triple reuptake inhibitor is a carboxylic acid ester prodrug of desvenlafaxine. It is currently under development for the treatment of major depressive disorder - a frequent and heterogeneous disorder induced by a complex pattern of genetic, epigenetic, developmental, and environmental factors.

Ključne riječi

Ansofaxine; Antidepressant

Hrčak ID:

245985

URI

https://hrcak.srce.hr/245985

Datum izdavanja:

20.11.2020.

Posjeta: 1.717 *